Die Yang
Director/Board Member at Shanghai Guo Chuang Pharmaceutical Co., Ltd.
Network origin in Die Yang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
 Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China.
16
| Holding Company | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Die Yang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director/Board Member | |
China Nuokang Bio-Pharmaceutical, Inc.
 China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Pharmaceuticals: Major | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree Doctorate Degree | |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Chicago | College/University | Graduate Degree | |
| Nanjing University | College/University | Masters Business Admin | |
| National Taiwan University | College/University | Undergraduate Degree | |
| Tsinghua University | College/University | Masters Business Admin | |
Cathay Industrial Biotech Ltd.
 Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Chemicals: Specialty | Director/Board Member | |
| Productos Roche SA | Corporate Officer/Principal | ||
HBM BioMed China Partners Ltd
 HBM BioMed China Partners Ltd Investment ManagersFinance HBM BioMed China Partners Ltd. is a venture capital fund focused on biomedical investments in companies based in China. | Investment Managers | Chairman | |
| Pharmaceutical Association of Shijiazhuang City | President | ||
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| Harbin University of Commerce | College/University | Undergraduate Degree | |
Shanghai Roche Pharmaceutical Co., Ltd.
 Shanghai Roche Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche (China) Co. Ltd., Shanghai Roche Pharmaceutical Co., Ltd. is a company that manufactures pharmaceutical products. Shanghai Roche Pharmaceutical Co., Ltd. is based in Shanghai, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Roche (China) Co. Ltd. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
| China University of Political Science & Law | College/University | Graduate Degree | |
| Produtos Roche Químicos e Farmacêuticos SA | Biotechnology | Corporate Officer/Principal | |
| Heilongjiang University of Chinese Medicine | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| China Pharmaceutical University | College/University | Doctorate Degree | |
| School of Economics & Business Administration | College/University | Undergraduate Degree | |
| Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd | Corporate Officer/Principal | ||
| DIAN DIAGNOSTICS GROUP CO.,LTD. | Medical/Nursing Services | Director/Board Member | |
| Keller Pharma Consultancy (Shanghai) Co. Ltd. | Founder | ||
Coland Pharmaceutical Co., Ltd.
 Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chairman | |
| COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Shanghai Ocean University | College/University | Undergraduate Degree | |
| Shanghai Association of Enterprises With Foreign Investment | Director/Board Member | ||
| HANGZHOU TIGERMED CONSULTING CO., LTD | Miscellaneous Commercial Services | Chairman | |
| Anhui University of Chinese Medicine | College/University | Undergraduate Degree | |
| SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. | Medical Specialties | Director/Board Member | |
| GOOGOL TECHNOLOGY CO., LTD. | Electrical Products | Director/Board Member | |
Shanghai LIDE Biotech Co. Ltd.
 Shanghai LIDE Biotech Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai LIDE Biotech Co. Ltd. is a translational medicine service provider that specializes in oncology translational research and immuno oncology. The private company is based in Shanghai, China. The Chinese company has a growing bank of over 50 cell line-derived xenograft (cdx) mouse models that are used for preclinical drug efficacy testing. The benefits of cdx models are their cost effectiveness, fast turnaround time, and high efficiency of xenotransplantation. LIDE's FGI (Functional Genomic Imaging) platform leverages its K-cell technology and bioinformatics team to deliver next-generation transcription analysis. The primary benefit of CR (Conditionally Reprogrammed) cells is their intratumor and intertumor heterogeneity, even after amplification. | Miscellaneous Commercial Services | Director/Board Member | |
| Heilongjiang Province Tongze Pharmaceutical Co. Ltd. | Chief Executive Officer | ||
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member | |
| HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| CATHAY BIOTECH INC. | Chemicals: Specialty | Director/Board Member | |
| Fosun Pharma Group Co. Ltd. | Director/Board Member | ||
| Roche Diagnóstica Brasil Ltda | Corporate Officer/Principal |
Statistics
International
| China | 31 |
| Cayman Islands | 6 |
| United States | 4 |
| Brazil | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 14 |
| Process Industries | 3 |
| Health Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 31 |
| Independent Dir/Board Member | 13 |
| Corporate Officer/Principal | 10 |
| Undergraduate Degree | 7 |
| Chairman | 6 |
Most connected contacts
| Insiders | |
|---|---|
| William Keller | 26 |
| Xiao Ping Ye | 9 |
| Jiang Min Wei | 4 |
| Ruo Hua Cao | 4 |
| Lu Zhang | 3 |
| Mei Fang Ma | 2 |
| Yong Hua Wang | 2 |
| Li Yang Shi | 2 |
| Chun Pu Zou | 2 |
| Zhu Li | 2 |
| Zhi Yong Zhao | 2 |
| Tong Wu | 2 |
| Liang Qiang Chen | 2 |
| Xiang Yin | 2 |
| Jun Zhang | 2 |
- Stock Market
- Insiders
- Die Yang
- Company connections
